Paediatric Vaccination Programme (ages 5 to 11 years)
Vaccinations for children turning 12
Until recently, if a child had a paediatric dose of Comirnaty (Pfizer's COVID-19 vaccine) at age 11 and then turned 12 before their second dose, the second dose would still be a paediatric dose. This has now changed.
- Children aged 5-11 should still get a paediatric dose of Comirnaty as their first dose, but if they turn 12 before their second dose, they will now receive the adult dose of Comirnaty as their second dose.
- An 8-week gap is recommended between the paediatric and adult doses.
Mixed schedules
- Children aged 12 and over can receive either Comirnaty or Nuvaxovid (Novavax's COVID-19 vaccine), but a prescription is needed for Nuvaxovid if it is the second dose and/or part of a mixed schedule.
- Only Comirnaty paediatric doses are available for children aged under 12.
Immunocompromise
This change is particularly important for those children with complex health issues or immunocompromised, who are at higher risk from COVID-19, to ensure they are fully protected with vaccine doses appropriate for their age.
Note: New screening chart for Comirnaty is available here
After your child's Pfizer vaccination comes in pads of 100.
Vaccinating 5-11 year old's against COVID-19: course and guidance available 13 Jan 2022
5-11 comms - phase 2 15 Jan 2022
Resources from the MOH, the pack includes advertising visuals, and information for 5-11s COVID-19 Vaccination.
If access to Dropbox you can download these resources
You can also order them via the DHBs design and print team
Unite against Covid 19 Website & Protecting your Tamariki from Covid 19 brochure translations info sheet for tamariki languages
Cook Islands Maori and Cook Island Maori brochure
Kiribati and Kiribati brochure
Maori and Te Reo Maori brochure
Tokelauan and Tokelauan brochure
Tuvaluan and Tuvaluan brochure
Activity 1 COL IN Certificate
Activity 2 COL IN Maze
Activity 3 COL IN
Activity 4 Tamariki Time
Paediatric Pfizer COVID-19 Vaccination Providers
Useful places to find information:
health.govt.nz/CovidVaccineKids
covid19.govt.nz/tamariki
karawhiua.nz/frequently-asked-questions/
The Ministry of Health are planning to hold a webinar for the Primary Care sector in the next few weeks. These FAQs, sent out last year – may be useful and further down the MOH’s social media team’s Q&A of conversations.
FAQs
What is this COVID-19 immunisation being offered and who is it for?
This is the COVID-19 vaccine for tamariki aged 5 to 11 years.
Parents and caregivers have the opportunity to protect their tamariki aged 5 to 11 against COVID-19, by being immunised with a child (paediatric) formulation of the Pfizer vaccine.
How the programme will run?
Immunisations for tamariki start around the motu on 17 January.
The Ministry of Health is working with DHBs, and community organisations to roll out the Pfizer vaccine to children in ways that suit whānau and communities. If you wish for your child to be immunised, your child will receive the Pfizer COVID-19 children’s vaccine. It has the same active ingredients as the vaccine given to adults, but as a smaller dosage. Some immunisation clinics may also offer other childhood immunisations such as MMR. It is okay to get several vaccines at the same time.
How is this different to the COVID-19 vaccine that is already available to people aged 12 and over?
The vaccine used for tamariki is a children’s version of the Pfizer vaccine, with a lower dose and smaller volume.
How many doses do tamariki need?
Tamariki need two doses of the vaccine to be fully protected.
How many weeks or days apart are the two doses?
It is recommended that these are given at least 8 weeks apart. The interval can be shortened to a minimum of 21 days if needed, for example if your child is starting significant immunosuppression treatment.
Why should I get my child/children immunised?
Immunisation is an important way we keep tamariki safe, like being sun smart or wearing a seatbelt.
It protects your tamariki from many serious diseases and stops disease spreading within your whānau and the community. In Aotearoa, children get free vaccinations against 12 diseases, including whooping cough (pertussis), measles and polio.
The Ministry of Health recommends immunising your child to keep them safe and to help protect your whānau and community from COVID-19.
What are the benefits of immunisation against COVID-19?
The COVID-19 virus can be unpredictable. While COVID-19 generally has milder effects in children, with symptoms being similar to a cold, some tamariki become severely ill and require hospitalisation. In addition, tamariki can have rare complications such as Multisystem Inflammatory Syndrome (MIS-C) that may require intensive care. Tamariki can also suffer long term effects (known as long COVID), even after mild cases of COVID-19.
Like adults, if your tamariki are infected with COVID-19 they may transmit the virus to other people. Immunising 5 to 11-year-old tamariki helps protect whānau members whose health makes them more vulnerable to COVID-19.
Have there been any trials with children?
Yes, the Pfizer vaccine for 5 to 11-year-olds has been through clinical trials with children in this age group. In general, the side effects that were reported were mild, didn’t last long, and were similar to side effects from other routine vaccines.
What if a child has allergies?
The vaccine is recommended for tamariki with food allergies. Unlike some other vaccines, there is no food, gelatine or latex in the Pfizer vaccine.
The only reason that someone may not be able to have this vaccine due to allergy is if they have had a severe allergic response (anaphylaxis) to a previous dose of the Pfizer vaccine or an ingredient in the vaccine. The child (paediatric) Pfizer vaccine has gone through the same rigorous approval process as other routine childhood vaccines. No clinical trials were skipped and no corners were cut in the testing of its safety.
How was the vaccine approved in Aotearoa New Zealand?
In Aotearoa New Zealand, Medsafe granted provisional approval of the Pfizer COVID-19 vaccine for children aged 5 to 11 years old. Medsafe only grants approval for a vaccine or medicine once it is satisfied that it has met internationally-agreed criteria for quality, safety and efficacy.
Cabinet has now approved the decision to use the paediatric vaccine for this cohort following advice from the Ministry of Health with guidance from the COVID-19 Vaccine Technical Advisory Group (CV TAG). A group of New Zealand paediatricians including leading Māori and Pacific clinicians were consulted by CV-TAG to prepare this guidance. The FDA in the United States and the TGA in Australia have also granted provisional approval or emergency use authorisation for the Pfizer COVID-19 vaccine for 5 to 11 year olds. The vaccine is currently being rolled out in the United States to this age group.
What advice do you have for preparing tamariki for vaccination?
- Provide encouragement to help your tamariki feel relaxed
- Make sure they have had something to eat and drink
- Check they’re wearing clothes that make it easy to see and access their upper arm.
If they’re a little nervous, they’re welcome to take something to the appointment that will distract them, like a soft toy or phone.
If your tamariki have had previous reactions to immunisations, let your vaccinator know, speak to your whānau doctor prior to the appointment, or talk to a trained advisor on the COVID Vaccination Healthline - 0800 28 29 26.
Who can give consent?
A parent, caregiver or legal guardian will need to accompany your child to their appointment(s) as the responsible adult and be able to provide consent for them to be immunised.
At the appointment both the adult and child can ask as many questions as they like.
You can read more online in our policy here covid-19-vaccine-children-aged-5-11-years-policy-statement24dec2021.pdf
What are the side effects?
As with any immunisation, your child is likely to have a sore arm and get redness, pain or swelling at the injection site. Other reactions that can occur, usually within one or two days, include:
- headache
- a fever (feeling hot)
- nausea (feeling sick), vomiting, diarrhoea
- fatigue
- general discomfort (feeling unwell, aches and pains).
These are common and show that the vaccine is working. Encouraging rest and offering plenty of fluids will help.
Severe reactions to the Pfizer COVID-19 vaccine are very rare and usually occur straight away after the vaccination. For this reason, you and your child will be put in an observation area for monitoring by clinical staff to ensure they receive any medical treatment if this occurs.
Signs of severe allergic reaction can include:
- difficulty breathing
- swelling of the face and throat
- a fast heartbeat
- a bad rash all over the body
- dizziness and weakness
If you notice your child experiencing any of these symptoms let clinical staff know immediately. If you are not at a vaccination site call 111.
Myocarditis and pericarditis are very rare but serious side effects of the Pfizer vaccine. In the clinical trials no cases were seen in children aged 5 to 11 years old, however it is important to be aware of the symptoms for all ages who are vaccinated. If your child has any of the following symptoms in the days or weeks after being vaccinated, get medical help right away.
Symptoms of myocarditis and pericarditis:
- discomfort, heaviness, tightness or pain in their chest
- difficulty breathing
- feelings of having a fast-beating, fluttering, or pounding heart
- feeling faint, light-headed or dizzy
Is it free to get vaccinated?
COVID-19 immunisations are free for everyone.
How do we get our tamariki vaccinated?
Book or walk in
COVID-19 immunisations are free for everyone. Parents or caregivers can book their tamariki at BookMyVaccine.nz (from 17 January) to get immunised with their usual health provider, hauora, pharmacy, or general practice (make sure you select the appropriate age range).
You can also check if your nearest walk-in vaccination centre is offering tamariki vaccinations.
If you want to make a whānau booking or you’re unable to book online, you can call the COVID Vaccination Healthline on 0800 28 29 26 (8am to 8pm, 7 days a week) and we’ll make the booking for you and answer any questions. Interpreters are available.
What if my tamariki has a disability?
The disability team is available Monday to Friday, from 8am to 8pm. They will support your whānau and can book an immunisation appointment for you. They can answer any questions you may have about your child’s needs including accessibility, free transport options, or any effects the vaccine may have on your child.
- Call: 0800 28 29 26 and push 2
- Free text: 8988
- Email: accessiblecovidvaccinations@whakarongorau.nz
Where can I get more information?
For more information and links to research, visit health.govt.nz/CovidVaccineKids, Karawhiua, Ministry for Pacific Peoples and covid19.govt.nz/tamariki
If you have questions about the vaccine, talk to a trained advisor on the COVID Vaccination Healthline - 0800 28 29 26 - between 8am–8pm, 7 days a week.
Social media team Q&A
| Question | MoH response |
|---|---|
| Is the same dose given to all children regardless of size and age?If so, please provide studies regarding the different dosage effects in line with body mass? | The BMI/weight of our tamariki is unrelated to the immune response. The maturity of the immune system is what counts.Pfizer completed safety trials before licensure to find the optimal dose for each age group., Each age group has a calibrated dose to optimise their immune response– 10 micrograms is optimal for 5 - 11 age group and 30 micrograms for the 12+ age group. |
| Is the child (paediatric) dose the same as the adult dose of the Pfizer vaccine? | The vaccine used for tamariki is a children’s version of the Pfizer vaccine, with a lower dose and smaller volume (one third of the adult dose.). The lower dose was chosen based on a trial which showed the lower dose was safe and had few side effects in this age group. |
| I’ve heard the child dose of the paediatric vaccine includes Tromethamine? | The COVID-19 Pfizer vaccine for tamariki aged 5-11 includes a change to the ingredients and the amount of ingredients in the vial, including the concentration of mRNA (active ingredient). These ingredients help extend the shelf life of the vaccine. This is a lower dose product developed especially for children under 12 who produce an appropriately strong immune response at lower doses than the adult dose. The COVID-19 Pfizer vaccine for tamariki aged between 5-11 includes the following ingredients: mRNA, lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 2 [(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3-phosphocholine, and cholesterol), tromethamine, tromethamine hydrochloride, sucrose, and sodium chloride. The use of the different inactive ingredients helps stabilize the vaccine under refrigerated temperatures and the formulation can be readily prepared to deliver appropriate doses to the 5- to 11-year-old population. |
| If my child will turn 12 between my first and second dose, will they receive one child dose and one adult dose? | If a child has their second vaccination after they have turned 12, they should still complete their vaccination course with the paediatric formulation of the Pfizer vaccine. |
| Can my family member accompany my child to get their vaccine while I’m at work? | A parent, caregiver or legal guardian will need to accompany your child to their appointment(s) as the responsible adult and provide consent for them to be immunised. |
| What studies have been done for this age group? | You can find Pfizer results from the trial of COVID-19 vaccine in children ages 5 to 11 here: pfizer.com/news/press-releases You can also find more information here: COVID-19 vaccine and children: Information for parents and caregivers | Ministry of Health NZ |
| What’s the point as kids don’t die of Covid/ The vaccine is a greater risk for this age group ! | The COVID-19 virus can be unpredictable. While COVID-19 generally has milder effects in children, with symptoms being similar to a cold, some tamariki become severely ill and require hospitalisation. In addition, tamariki can have rare complications such as Multisystem Inflammatory Syndrome (MIS-C) that may require intensive care. Tamariki can also suffer long term effects (known as long COVID), even after mild cases of COVID-19. Like adults, if your tamariki are infected with COVID-19 they may transmit the virus to other people. Immunising 5 to 11-year-old tamariki helps protect whānau members whose health makes them more vulnerable to COVID-19. |
| How much time should be left between doses for tamariki? | Tamariki need two doses of the vaccine to be fully protected. It is recommended that these are given at least 8 weeks apart. The interval can be shortened to a minimum of 21 days if needed, for example if your child is starting significant immunosuppression treatment. |
| Will my tamariki be given their vaccine at school? | While there are no plans for a school-based immunisation programme, schools are being considered as community vaccination sites. This will add capacity to the vaccination network and make it even easier for families to get vaccinated. |
| Can my tamariki get their COVID-19 vaccine at the same time as other childhood immunisations? | Some immunisation clinics may also offer other childhood immunisations such as MMR. It is okay to get several vaccines at the same time. |
| How do we know if the vaccine is safe for tamariki? | The Pfizer vaccine for 5- to 11-year-olds has been through clinical trials with tamariki in this age group. In general, the side effects that were reported were mild, didn’t last long, and were similar to side effects from other routine vaccines. |
| My child has food allergies, can they get the vaccine? | The vaccine is recommended for tamariki with food allergies. Unlike some other vaccines, there is no food, gelatin or latex in the Pfizer vaccine. The only reason that someone may not be able to have this vaccine due to allergy is if they have had a severe allergic response (anaphylaxis) to a previous dose of the Pfizer vaccine or an ingredient in the vaccine. The child (paediatric) Pfizer vaccine has gone through the same rigorous approval process as other routine childhood vaccines. No clinical trials were skipped, and no corners were cut in the testing of its safety. |
| Why can’t my child get the Astra Zeneca vaccine? | The AstraZeneca vaccine is approved for adults aged 18 and older. |
| What side effects could tamariki have? | As with any immunisation, your child is likely to have a sore arm and get redness, pain or swelling at the injection site. Other reactions that can occur, usually within one or two days, include a headache, a fever (feeling hot), nausea (feeling sick), vomiting, diarrhoea, fatigue or general discomfort (feeling unwell, aches and pains). These are common. Encouraging rest and offering plenty of fluids will help. You can find out more information here: COVID-19 vaccine and children: Information for parents and caregivers | Ministry of Health NZ |
| What support is on offer for a child with disabilities? |
The disability team is available Monday to Friday, from 8am to 8pm. They will support your whānau and can book an immunisation appointment for you. They can answer any questions you may have about your child’s needs including accessibility, free transport options, or any effects the vaccine may have on your child. Call 080028 29 26 and push 2, free text 8988 or email accessiblecovidvaccinations@whakarongorau.nz |
| Will children 5- to 11-years-old be required to have a My Vaccine Pass to access non-essential services? | There is no vaccine mandate for tamariki. It is completely up to the parents or caregivers to decide if they want their children vaccinated |
| Will certain populations be prioritised for the paediatric vaccine rollout? | We are working with iwi, DHBs, local providers, communities, and the Ministry of Education to roll out the Pfizer vaccine to children in a whānau-based model. Some clinics may also offer other childhood immunisations. |
| How many paediatric vaccines has NZ ordered and when will they arrive? | Officials are currently in discussion with Pfizer to determine the earliest delivery date. This is expected as early as next month, with the rollout to start no later than the end of January.We will have access to enough doses to vaccinate all 5–11 year-old New Zealanders as well as those turning 5 in 2022. |
| Will NZ provide paediatric vaccines to the Pacific? | New Zealand officials are in discussion with health officials from the Realm and Pacific countries to discuss the potential rollout of Pfizer paediatric vaccines, and whether the individual countries wish to do so. |